As of 2024, Germany leads diuretic medicine sales per capita with USD 8.4, followed by Slovenia at USD 3.2. The market has seen various changes from 2023, with Germany growing by 3.71%, and notable declines in Belgium (-4.66%) and Greece (-8.29%). Conversely, Australia and New Zealand grew by 4.84% and 4.56%, respectively. Over five years, varying average growth rates highlight diverse trends among countries, influenced by healthcare policies, demographic shifts, and medical environments.
Future trends to watch include the expansion of diuretic medicine in emerging markets and innovations leading to new formulations. Additionally, aging populations in developed countries may drive sustained demand, while regulatory changes could either hinder or facilitate market growth.
Top countries in Diuretic Medicine Sales by Country
| # | 10 Countries | US Dollars Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 8.4 | 2023 | +1.2% | +3.71% | View data |
| 2 | 2 Slovenia | 3.2 | 2023 | 0% | -1.78% | View data |
| 3 | 3 Norway | 2.8 | 2023 | 0% | -1.37% | View data |
| 4 | 4 Spain | 2.7 | 2023 | 0% | -0.72% | View data |
| 5 | 5 Belgium | 2.6 | 2023 | 0% | -4.66% | View data |
| 6 | 6 Czech Republic | 2.5 | 2023 | +4.17% | +1.68% | View data |
| 7 | 7 Greece | 2.4 | 2023 | +4.35% | -8.29% | View data |
| 8 | 8 Italy | 2.2 | 2023 | +4.76% | -0.89% | View data |
| 9 | 9 Portugal | 2 | 2023 | -4.76% | -4.36% | View data |
| 10 | 10 Finland | 2 | 2023 | 0% | +2.13% | View data |
